Medical Device Investing Knight Therapeutics Announces Health Canada Approval for JORNAY PM to Treat Attention-Deficit Hyperactivity Disorder
Medical Device Investing Knight Therapeutics Inc. places No. 397 on The Globe and Mail's sixth annual ranking of Canada's Top Growing Companies
Medical Device Investing Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America
Medical Device Investing Knight Therapeutics Inc. announces voting results from the Annual General Meeting
Medical Device Investing Knight to Present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City
Medical Device Investing Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Medical Device Investing Knight Therapeutics Inc. ranks on The Globe and Mail's fifth-annual Women Lead Here benchmark of executive gender diversity
